Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220940416
Abstract: Introduction Isavuconazole is increasingly being used for antifungal prophylaxis during stem cell transplantation. Isavuconazole is a moderate inhibitor of Cytochrome P4503A4, and tacrolimus levels are anticipated to be elevated when given concomitantly with isavuconazole. We… read more here.
Keywords: cell transplantation; stem cell; 017 day; tacrolimus dose ... See more keywords